Skip to main content
|
Go home
Go home

Clinical Trials Offer Hope

Close-up illustration of blue DNA double helix strands on a light blue abstract background.

On the Horizon. As the first academic and clinical research enterprise in Nevada, Renown Health and the University of Nevada, Reno School of Medicine partner to provide access to the region’s most advanced clinical trials. Our Office of Clinical Research supports numerous research efforts in various specialties and actively seeks new collaborations. Dozens of open clinical trials, including these, are currently underway at Renown Health.

Genetics

STUDY TITLE: M/NASH
Full protocol title: Nonalcoholic Steatohepatitis Liver Disease Genome Atlas Indication: Metabolic and nonalcoholic steatohepatitis
Phase: II
PI name: Joseph Grzymski, PhD
Phone number: 775-982-6914

Oncology

STUDY TITLE: EXAI CP-23001
Full protocol title: A Prospective Study of oncRNA Stratification of Cancer by Size and Stage
Indication: multi-disease site cancer stratification by size and stage & healthy controls
NCT number: NCT05833360
Phase: Not Applicable
PI name: Lee Schwartzberg, MD
Phone number: 775-982-5050

Pediatrics

STUDY TITLE: VAD00004 (PEARL)
Full protocol title: Efficacy, Immunogenicity, and Safety Study of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers
Indication: Respiratory syncytial virus (RSV)
NCT number: NCT06252285
Phase: II
PI name: Sonia Budhecha, MD
Phone number: 775-982-3646

Pulmonology

STUDY TITLE: PROACT-LUNG
Full protocol title: The PROACT LUNG Study: A Prospective, Observational, Clinical Validation Study of the Freenome Multiomics Blood Test for Lung Cancer Screening (FRNM-007)
Indication: Lung cancer
NCT number: 06122077
Phase: Observational
PI name: Farah Madhani Lovely, MD
Phone number: 775-982-7532

Rheumatology

STUDY TITLE: TOPAZ-2 230LE304
Full protocol title: A Multicenter, Randomized, Double-Blind, Placebo Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Litifilimab (BIIB059) in Adult Participants With Active Systemic Lupus Erythematosus Receiving Background Nonbiologic Lupus Standard of Care
Indication: Systemic lupus erythematosus (SLE)
NCT number: 04961567
Phase: IIII
PI name: Kennedy Ukadike, MD
Phone number: 775-982-6128

Click here to learn more about open Clinical Trials available at Renown Health.

Related Blogs

Group of students rushing through a school hallway, carrying backpacks and chatting excitedly as they transition between classes

Why the HPV Vaccine Matters for Kids and Teens

As the back-to-school season approaches, ensuring your child is ready for a successful academic year goes beyond school supplies and new clothes. It's also the perfect time to prioritize their health by ensuring they're up-to-date on essential vaccinations, including the HPV vaccine.
Read More Why the HPV Vaccine Matters for Kids and Teens
Studio Portrait Of Boy Dressed As Comic Book Superhero Against Magical Background

Protect Your Child’s Health with Timely Vaccinations

Why are timely vaccinations important? Childhood vaccinations are scheduled and vaccines are administered when young bodies require immediate protection or need to build immunity for diseases and illnesses we may encounter throughout our lives. Delaying recommended vaccinations puts children at higher risk for diseases that can affect them more harshly, like pertussis (whooping cough), which is especially dangerous for babies.
Read More Protect Your Child’s Health with Timely Vaccinations
View All Blogs

Related Events

View All Classes & Events
ER Wait Times

How are wait times calculated?

Our estimated ER wait times reflect the average time from check-in to being seen by a medical professional during triage, where patients are prioritized based on the severity of their condition.